Nle: Norleucine
10.1053/j.ajkd.2018.06.028 [DOI] [PubMed] [Google Scholar] 320.Kohagura, K
Chang E, Weinstock C, Zhang L, Charlab R, Dorff SE, Gong Y, Hsu V, Li F, Ricks TK et al (2021) fda approval summary: enfortumab vedotin for locally advanced or metastatic urothelial carcinoma FDA approval summary: enfortumab vedotin
Supraphysiological T3/T4 Excessive thyroid hormone (iatrogenic hyperthyroidism, T3 abuse in body-composition contexts) accelerates IGF-1 clearance and increases GH secretion
Prx6 operates through its function as a selenium acceptor protein, channeling reactive selenium species toward the biosynthesis of selenoproteins, especially GPX4
Long CA, Boulom V, Albadawi H, Tsai S, Yoo HJ, Oklu R, et al